应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CAPR Capricor Therapeutics Inc
提前休市 07-03 13:00:00 EDT
4.83
+0.11
+2.33%
盘后
4.76
-0.07
-1.45%
14:59 EDT
最高
4.87
最低
4.65
成交量
28.28万
今开
4.73
昨收
4.72
日振幅
4.56%
总市值
1.54亿
流通市值
1.28亿
总股本
3,198万
成交额
135.28万
换手率
1.06%
流通股本
2,656万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-Capricor Therapeutics因肌肉失调疗法的长期安全性数据而上涨
Reuters · 06-28
BUZZ-Capricor Therapeutics因肌肉失调疗法的长期安全性数据而上涨
Capricor Therapeutics, Inc.盘中异动 快速拉升5.60%
自选股智能写手 · 06-28
Capricor Therapeutics, Inc.盘中异动 快速拉升5.60%
Capricor Therapeutics, Inc.盘中异动 急速上涨5.64%
自选股智能写手 · 06-25
Capricor Therapeutics, Inc.盘中异动 急速上涨5.64%
Capricor Therapeutics, Inc.盘中异动 早盘急速下跌5.05%报5.27美元
自选股智能写手 · 06-12
Capricor Therapeutics, Inc.盘中异动 早盘急速下跌5.05%报5.27美元
Capricor Therapeutics, Inc.盘中异动 大幅跳水5.11%报5.20美元
自选股智能写手 · 06-08
Capricor Therapeutics, Inc.盘中异动 大幅跳水5.11%报5.20美元
Capricor Therapeutics, Inc.盘中异动 早盘快速下挫5.00%报5.51美元
自选股智能写手 · 06-05
Capricor Therapeutics, Inc.盘中异动 早盘快速下挫5.00%报5.51美元
Capricor Therapeutics, Inc.盘中异动 早盘股价大涨5.14%
自选股智能写手 · 06-04
Capricor Therapeutics, Inc.盘中异动 早盘股价大涨5.14%
Capricor Therapeutics, Inc.盘中异动 股价大涨5.34%报5.85美元
自选股智能写手 · 05-31
Capricor Therapeutics, Inc.盘中异动 股价大涨5.34%报5.85美元
Capricor Therapeutics, Inc.盘中异动 大幅下跌5.10%
自选股智能写手 · 05-29
Capricor Therapeutics, Inc.盘中异动 大幅下跌5.10%
Capricor Therapeutics, Inc.盘中异动 股价大跌5.01%
自选股智能写手 · 05-28
Capricor Therapeutics, Inc.盘中异动 股价大跌5.01%
Capricor Therapeutics(CAPR.US)获奥本海默首次覆盖,给予优于大市评级, 目标价14.00美元。
智通财经 · 05-17
Capricor Therapeutics(CAPR.US)获奥本海默首次覆盖,给予优于大市评级, 目标价14.00美元。
Ladenburg Thalmann:维持Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至25.00美元。
智通财经 · 05-15
Ladenburg Thalmann:维持Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至25.00美元。
Capricor Therapeutics, Inc.盘中异动 快速跳水6.25%报5.10美元
自选股智能写手 · 05-14
Capricor Therapeutics, Inc.盘中异动 快速跳水6.25%报5.10美元
Capricor Therapeutics Inc 预计每股亏损11美分 - 财报前瞻
Reuters · 05-07
Capricor Therapeutics Inc 预计每股亏损11美分 - 财报前瞻
Capricor Therapeutics, Inc.盘中异动 早盘股价大涨5.32%
自选股智能写手 · 05-03
Capricor Therapeutics, Inc.盘中异动 早盘股价大涨5.32%
Capricor Therapeutics, Inc.盘中异动 快速上涨5.03%
自选股智能写手 · 04-29
Capricor Therapeutics, Inc.盘中异动 快速上涨5.03%
Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%
自选股智能写手 · 04-26
Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%
HC Wainwright & Co.:重申Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价40.00美元。
智通财经 · 04-25
HC Wainwright & Co.:重申Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价40.00美元。
Capricor Therapeutics, Inc.盘中异动 下午盘快速下跌5.23%报5.62美元
自选股智能写手 · 04-18
Capricor Therapeutics, Inc.盘中异动 下午盘快速下跌5.23%报5.62美元
Capricor Therapeutics, Inc.盘中异动 快速下跌5.12%报5.93美元
自选股智能写手 · 04-16
Capricor Therapeutics, Inc.盘中异动 快速下跌5.12%报5.93美元
加载更多
公司概况
公司名称:
Capricor Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于开发转化细胞和外泌体疗法,用于治疗Duchenne肌营养不良症(DMD),这是一种罕见的肌肉营养不良症,会导致肌肉退化和过早死亡,以及其他医疗需求未得到满足的疾病。自成立以来,该公司投入了大量资源开发CAP-1002和他们的其他候选产品,包括他们的外泌体平台,开发他们的制造流程,为公司配备人员,并为这些业务提供行政支持。该公司没有任何获准销售的产品。公司能否最终产生足以实现盈利的任何产品收入,将取决于用于治疗DMD和其他候选产品的CAP-1002的成功开发、批准和最终商业化。
发行价格:
--
{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":4.83,"timestamp":1720026000000,"preClose":4.72,"halted":0,"volume":282781,"hourTrading":{"tag":"盘后","latestPrice":4.76,"preClose":4.83,"latestTime":"14:59 EDT","volume":203,"amount":966.3701,"timestamp":1720033149102},"delay":0,"floatShares":26556391,"shares":31979266,"eps":-0.858971,"marketStatus":"提前休市","marketStatusCode":6,"change":0.11,"latestTime":"07-03 13:00:00 EDT","open":4.73,"high":4.865,"low":4.65,"amount":1352754.824708,"amplitude":0.045551,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.858971,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720166400000},"adr":0,"adjPreClose":4.72,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":4.76,"preClose":4.83,"latestTime":"14:59 EDT","volume":203,"amount":966.3701,"timestamp":1720033149102},"volumeRatio":0.444818,"impliedVol":1.4759,"impliedVolPercentile":0.8016},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"2446689433","title":"BUZZ-Capricor Therapeutics因肌肉失调疗法的长期安全性数据而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2446689433","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446689433?lang=zh_cn&edition=full","pubTime":"2024-06-28 22:44","pubTimestamp":1719585840,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月28日 - ** 药物开发商 Capricor Therapeutics 的 股价上涨 8.6% 至 5.04 美元** 公司宣布,正在进行的测试其主要实验性疗法 deramiocel 的中期研究的三年安全性和疗效数据良好** 该疗法是为治疗杜兴氏肌肉萎缩症而开发的,杜兴氏肌肉萎缩症是一种遗传性疾病,会导致骨骼肌和心肌无力** 数据显示","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2446688239","title":"Capricor Therapeutics, Inc.盘中异动 快速拉升5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446688239","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446688239?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:44","pubTimestamp":1719582254,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时44分,Capricor Therapeutics, Inc.股票出现异动,股价大幅上涨5.60%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214414941f251c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214414941f251c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2446950849","title":"Capricor Therapeutics, Inc.盘中异动 急速上涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446950849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446950849?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:39","pubTimestamp":1719322796,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时39分,Capricor Therapeutics, Inc.股票出现波动,股价急速上涨5.64%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213956af8f207b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213956af8f207b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2442265565","title":"Capricor Therapeutics, Inc.盘中异动 早盘急速下跌5.05%报5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442265565","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442265565?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:51","pubTimestamp":1718203902,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时51分,Capricor Therapeutics, Inc.股票出现异动,股价大幅下跌5.05%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061222514296813c0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061222514296813c0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR","BK4139"],"gpt_icon":0},{"id":"2441090926","title":"Capricor Therapeutics, Inc.盘中异动 大幅跳水5.11%报5.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441090926","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441090926?lang=zh_cn&edition=full","pubTime":"2024-06-08 03:18","pubTimestamp":1717787932,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日03时18分,Capricor Therapeutics, Inc.股票出现波动,股价大幅下挫5.11%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608031852aef41621&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608031852aef41621&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2441440208","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速下挫5.00%报5.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441440208","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441440208?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:25","pubTimestamp":1717601140,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日23时25分,Capricor Therapeutics, Inc.股票出现异动,股价大幅下跌5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.29%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605232540af8c2bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605232540af8c2bf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2440823511","title":"Capricor Therapeutics, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440823511","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440823511?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:35","pubTimestamp":1717508139,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时35分,Capricor Therapeutics, Inc.股票出现异动,股价大幅上涨5.14%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060421353996811df1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060421353996811df1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR","BK4139"],"gpt_icon":0},{"id":"2439915522","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.34%报5.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439915522","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439915522?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:51","pubTimestamp":1717167062,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日22时51分,Capricor Therapeutics, Inc.股票出现波动,股价急速上涨5.34%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.22%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531225102aef2cf69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531225102aef2cf69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2439729785","title":"Capricor Therapeutics, Inc.盘中异动 大幅下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439729785","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439729785?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:47","pubTimestamp":1716997628,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时47分,Capricor Therapeutics, Inc.股票出现异动,股价大幅下跌5.10%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.98%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529234709aef2595a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529234709aef2595a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2438430558","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438430558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438430558?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:27","pubTimestamp":1716906455,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日22时27分,Capricor Therapeutics, Inc.股票出现波动,股价快速下跌5.01%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.81%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528222735aef21c73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528222735aef21c73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2436918779","title":"Capricor Therapeutics(CAPR.US)获奥本海默首次覆盖,给予优于大市评级, 目标价14.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2436918779","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436918779?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:05","pubTimestamp":1715940345,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics(CAPR.US)获奥本海默首次覆盖,给予优于大市评级, 目标价14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171805498b122e3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171805498b122e3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR"],"gpt_icon":0},{"id":"2435428745","title":"Ladenburg Thalmann:维持Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435428745","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435428745?lang=zh_cn&edition=full","pubTime":"2024-05-15 02:34","pubTimestamp":1715711699,"startTime":"0","endTime":"0","summary":"Ladenburg Thalmann:维持Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150235038b08940c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150235038b08940c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ"],"gpt_icon":0},{"id":"2435516895","title":"Capricor Therapeutics, Inc.盘中异动 快速跳水6.25%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435516895","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435516895?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:32","pubTimestamp":1715693554,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时32分,Capricor Therapeutics, Inc.股票出现波动,股价急速下挫6.25%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132348b07d786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132348b07d786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2433208053","title":"Capricor Therapeutics Inc 预计每股亏损11美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433208053","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433208053?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:05","pubTimestamp":1715083538,"startTime":"0","endTime":"0","summary":" * Capricor Therapeutics Inc 将于5月13日公布截至2024年3月31日的季度财报,预计该公司的季度收入将有所增长。* LSEG 分析师对 Capricor Therapeutics Inc 的平均预期是每股亏损 11 美分。* 华尔街对 Capricor Therapeutics Inc 的 12 个月目标价中位数为 18.00 美元,高于其上次收盘价 5.53 美元。5月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","LENZ"],"gpt_icon":0},{"id":"2432906618","title":"Capricor Therapeutics, Inc.盘中异动 早盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432906618","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432906618?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:25","pubTimestamp":1714746302,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日22时25分,Capricor Therapeutics, Inc.股票出现异动,股价快速上涨5.32%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032225037a57fc9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032225037a57fc9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2431865476","title":"Capricor Therapeutics, Inc.盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431865476","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431865476?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:33","pubTimestamp":1714397638,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时33分,Capricor Therapeutics, Inc.股票出现波动,股价大幅上涨5.03%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292133587924ec21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292133587924ec21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2430208091","title":"Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430208091","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430208091?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:52","pubTimestamp":1714139568,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时52分,Capricor Therapeutics, Inc.股票出现波动,股价大幅上涨5.05%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。该信息摘要如下:HC Wainwright & Co.:重申Capricor Therapeutics评级,由买入调整至买入评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262152497923fc04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262152497923fc04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR","BK4139"],"gpt_icon":0},{"id":"2430409001","title":"HC Wainwright & Co.:重申Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430409001","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430409001?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:37","pubTimestamp":1714045034,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Capricor Therapeutics(CAPR.US)评级,由买入调整至买入评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042519371587af1019&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042519371587af1019&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR"],"gpt_icon":0},{"id":"2428788873","title":"Capricor Therapeutics, Inc.盘中异动 下午盘快速下跌5.23%报5.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428788873","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428788873?lang=zh_cn&edition=full","pubTime":"2024-04-18 02:58","pubTimestamp":1713380318,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日02时58分,Capricor Therapeutics, Inc.股票出现异动,股价快速下挫5.23%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418025838792147e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418025838792147e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2427388630","title":"Capricor Therapeutics, Inc.盘中异动 快速下跌5.12%报5.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427388630","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427388630?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:28","pubTimestamp":1713198495,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时28分,Capricor Therapeutics, Inc.股票出现异动,股价大幅下挫5.12%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160028167920a5e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160028167920a5e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":0.0172},{"period":"1month","weight":-0.169},{"period":"3month","weight":-0.3059},{"period":"6month","weight":-0.1094},{"period":"1year","weight":0.0043},{"period":"ytd","weight":-0.0348}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于开发转化细胞和外泌体疗法,用于治疗Duchenne肌营养不良症(DMD),这是一种罕见的肌肉营养不良症,会导致肌肉退化和过早死亡,以及其他医疗需求未得到满足的疾病。自成立以来,该公司投入了大量资源开发CAP-1002和他们的其他候选产品,包括他们的外泌体平台,开发他们的制造流程,为公司配备人员,并为这些业务提供行政支持。该公司没有任何获准销售的产品。公司能否最终产生足以实现盈利的任何产品收入,将取决于用于治疗DMD和其他候选产品的CAP-1002的成功开发、批准和最终商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.171511},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.017849},{"month":3,"riseRate":0.555556,"avgChangeRate":0.019788},{"month":4,"riseRate":0.4,"avgChangeRate":0.465721},{"month":5,"riseRate":0.3,"avgChangeRate":-0.145751},{"month":6,"riseRate":0.6,"avgChangeRate":0.038271},{"month":7,"riseRate":0.4,"avgChangeRate":0.113652},{"month":8,"riseRate":0.555556,"avgChangeRate":0.02228},{"month":9,"riseRate":0.333333,"avgChangeRate":0.15128},{"month":10,"riseRate":0,"avgChangeRate":-0.146319},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.089676},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.114866}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}